The Clarity™ Prenatal Test

Non-invasive access to the fetal genome, offering comprehensive microarray analysis without the risks to the fetus posed by anmiocentesis and CVS, both invasive procedures.

Learn More

Isolating Fetal Cells

From fetal cells specific to the current pregnancy, isolated from a maternal blood sample, Cellscape can analyze the pure and complete fetal genome by a number of molecular techniques. CellScape uses the latest in microarray technology to generate reliable clinical results.

Learn More

About CellScape

Together with some of the foremost scientists and researchers in the world, the CellScape team is bringing innovative and reliable genetic testing to the field of prenatal medicine.

Learn More

Clinical Studies

The Clarity™ Test Trials – Now Enrolling

CellScape is currently enrolling sites for its clinical trials. If you are interested in learning more about being a trial site, please contact us. We look forward to working with you.

Learn More


November 21, 2013  Ob-Gyns Recommend Chromosomal Microarray Analysis for Genetic Evaluation of Fetal Anomalies

Committee Opinion #581, “The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis”

 August 21, 2013  Xconomy

Cellscape Hunts for Fetal Cells in Mom, Pushing Diagnostic Frontier

You can learn a lot about a potential human being if you can get your hands on a few red blood cells from a developing fetus. The thing is, these cells are fragile and hard… READ MORE »

Contact Us

CellScape Corporation

7979 Gateway Blvd., Suite 240

Newark, CA 94560


Contact Form

Please Note: The Clarity™ Prenatal Genetic Test is for investigational use only and is not currently marketed for sale.